MINNEAPOLIS, July 29 /EMWNews/ -- VASAMED, INC. (Pink

Sheets: VSMD) announced today that Craig M. Walker, M.D., has been elected

to the Company's board of directors increasing the number of directors from

four to five. Dr. Walker brings over 25 years of medical experience as a

practicing cardiologist, clinical investigator and thought leader.



    "Dr. Walker will be a great addition to our board. As one of the

world's leading experts in the care of patients with peripheral vascular

disease as well as the advances in the technology in support of this

mission, Dr. Walker will bring tremendous insight and perspective to our

organization," said Paulita LaPlante, VASAMED, president and chief

executive officer.



    Dr. Walker is the Founder, President, and Medical Director of the

Cardiovascular Institute of the South; Medical Director of the CIS

Cardiovascular Fellowship Training Program; Associate Clinical Professor of

Medicine Tulane University School of Medicine; and Medical Director of the

Cardiac Catheterization Laboratory at Terrebonne General Medical Center.



    Dr. Walker has been Principal Investigator in many cardiovascular

medical device clinical trials, and has made numerous presentations before

the FDA, medical conferences and symposia. He has published over 100

articles, abstracts and books. He is a graduate of the Louisiana State

University School of Medicine and is certified by the American Board of

Internal Medicine, American College of Physicians, American Board of

Internal Medicine -- Subspecialty of Cardiovascular Disease, American

College of Cardiology, American College of Angiology, American Society for

Laser Medicine and Surgery and Diplomat in Interventional Cardiology. Dr.

Walker completed his cardiology training at Harvard University's Brigham

and Women's Hospital, where he was a research fellow and clinical

instructor in cardiology and medicine.



    Dr. Walker is intimately involved in advancing innovative technology to

improve patients' lives. He is a Board of Director member for Cardiva, CV

Therapeutics, IDev and Spectranetics. He is a consultant to Boston

Scientific, Cardiva, CV Therapeutics, ev3, FlowMedica, IDev, Possis and

Spectranetics, serves on the speaker's bureau for Abbott, AstraZeneca,

Boston Scientific, Cardiva, Cordis, CV Therapeutics, FlowMedica, Possis,

Spectranetics and Toshiba; and is on the medical/scientific advisory board

for Cardiva, Edwards Lifesciences, FlowMedica, Philips, Spectranetics and

The Medicine Company.



    Commenting on his board appointment, Dr. Walker said, "VASAMED, is

committed to bringing the best noninvasive diagnostic hemodynamic products

to the medical community. In practice I have found the SensiLase(R)

System's skin perfusion pressure technology to be a valuable tool to

effectively identify patients with peripheral vascular disease, confirm

clinical outcomes and assist with patient care decisions."

    About VASAMED, INC.



    VASAMED designs, licenses, manufactures and distributes products that

are used by physicians in their clinic or procedure lab to determine a

patient's hemodynamic and lower extremity arterial health. VASAMED products

and technology are focused on measuring critical cardiovascular and

peripheral information and include SensiLase(R) Skin Perfusion Pressure and

Pulse Volume Recording System to measure capillary perfusion, AcQtrac(TM)

System to monitor heart function, and Tissue Carbon Dioxide Technologies,

featuring the MicroStat(TM) System, to monitor tissue wellness.